metricas
covid
Buscar en
Endocrinología, Diabetes y Nutrición (English ed.)
Toda la web
Inicio Endocrinología, Diabetes y Nutrición (English ed.) Prevalence of diabetes mellitus in Spain in 2016 according to the Primary Care C...
Journal Information
Vol. 68. Issue 2.
Pages 109-115 (February 2021)
Visits
3861
Vol. 68. Issue 2.
Pages 109-115 (February 2021)
Original article
Full text access
Prevalence of diabetes mellitus in Spain in 2016 according to the Primary Care Clinical Database (BDCAP)
Prevalencia de diabetes mellitus en 2016 en España según la Base de Datos Clínicos de Atención Primaria (BDCAP)
Visits
3861
Edelmiro Luis Menéndez Torrea,
Corresponding author
edelmiro.menendez@sespa.es

Corresponding author.
, Jessica Ares Blancoa, Santiago Conde Barreirob, Gemma Rojo Martínezc, Elías Delgado Alvareza, en representación del Grupo de Epidemiología de la Sociedad Española de Diabetes (SED)
a Servicio de Endocrinología y Nutrición, Hospital Universitario Central de Asturias, Universidad de Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
b Pediatría, Centro de Salud de Barbastro, Hospital de Barbastro, Barbastro, Huesca, Spain
c Servicio de Endocrinología y Nutrición, Hospital Regional de Málaga, IBIMA, Málaga, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (3)
Table 1. Prevalence (crude and adjusted to the Spanish population [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016.
Table 2. Prevalence (crude and adjusted [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016, in individuals aged 30 years or older (adjusted to the Spanish population).
Table 3. Prevalence (crude and adjusted [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016, in individuals aged 20–79 years or older (adjusted to the European population).
Show moreShow less
Abstract

The prevalence of type 2 diabetes mellitus is increasing worldwide, including in Spain, and this disease has become a major challenge for health care. In Spain, the computerization of medical records in primary care, in the Primary Care Clinical Database (BDCAP), has made possible the diagnoses of diabetes in a representative sample of the nation as a whole. This article analyzes the prevalence of diabetes recorded in this database and compares the data of the different autonomous communities (ACs).

The prevalence of diabetes in Spain is 6.66% of the total population assigned to primary care in the National Health System, is higher in men than in women (7.27% vs. 6.06%), and increases with age up to 80 years.

There are significant differences in the adjusted prevalence of diabetes between ACs, with lower prevalence rates in North and Central Spain and higher rates in the South and East, as well as the islands. The lowest prevalence is seen in Castile and León (4.51%), and the highest in the Canary Islands (9.72%).

Keywords:
Diabetes
Epidemiology
Spain
Resumen

La prevalencia de la diabetes tipo 2 está aumentando en todo el mundo incluido nuestro país, convirtiéndose en un enorme reto para la atención sanitaria. En España la informatización de la historia clínica en la Atención Primaria nos ha permitido disponer de los diagnósticos de diabetes de una muestra representativa de todo el territorio nacional, la Base de Datos Clínicos de Atención Primaria (BDCAP). En este trabajo se analiza la prevalencia de diabetes en esta base de datos y se compara la existente en las distintas comunidades autónomas (CCAA).

La prevalencia de diabetes en España es del 6,66% de la población total asignada a la Atención Primaria del Sistema Nacional de Salud, es mayor en hombres que en mujeres (7,27% vs 6,06%) y aumenta con la edad hasta los 80 años de edad.

Se observan unas diferencias importantes para las prevalencias ajustadas de diabetes entre unas CCAA y otras, siendo la prevalencia menor en las regiones del norte y centro de la península y mayor en el Sur y Este así como en las islas. La prevalencia más baja se observa en Castilla y León (4,51%) y la más alta en las Islas Canarias (9,72%).

Palabras clave:
Diabetes
Epidemiología
España
Full Text
Introduction

The prevalence of diabetes is increasing worldwide, similarly to that of obesity, and is reaching levels that constitute a genuine challenge for healthcare systems. According to the International Diabetes Federation (IDF), 451 million adults suffer from diabetes, and by the year 2045 this figure is expected to increase to 693 million, though with substantial differences among regions.1

Knowledge of the prevalence of diabetes is essential for determining the allocation of resources and to guide health and disease prevention policies, for in addition to its multiple complications, the disease is associated with increased mortality.2

In Spain, the progressive digitalization of health systems in primary care centres and the use of diagnostic coding systems have made possible the compiling of data corresponding to 2016 that are representative of all people diagnosed with diabetes in the country.

The purpose of the present study was to determine the prevalence of diagnosed diabetes compiled from primary care records in Spain and to analyse regional differences within the country, as well as the characteristics of the affected individuals in terms of age and gender.

Methods

The Primary Care Clinical Database (Base de Datos Clínicos de Atención Primaria [BDCAP]) of the Spanish National Health System has been developed for statistical and research purposes, with the consensus of all the Autonomous Communities (ACs) in the country and the National Institute of Health Management (Instituto Nacional de Gestión Sanitaria [INGESA]). The database annually collects standardized clinical information on the care provided at primary care level based on a large random sample (approximately 10%) of the medical records of the population assigned to that level of care, and is representative of each Spanish Autonomous Community.3

Data from people with the health problem coded as T89 (insulin-dependent diabetes) or T90 (non-insulin-dependent diabetes) in 2016 were extracted from the BDCAP from all the ACs, and by gender and 5-year age intervals.

For comparisons between ACs in Spain, prevalence was adjusted by the direct method to the Spanish population of that year according to the National Institute of Statistics (Instituto Nacional de Estadística [INS]), stratified by age and gender.

Taking into account the available data, and in order to establish comparisons by gender and among all the ACs, only data from people over 29 years of age in all ACs were considered.

For a comparative analysis with other European countries, the prevalence was adjusted to the standardized European population of 20134 at 5-year intervals and using the direct method.

Results

In 2016, a total of 2,956,121 people were diagnosed with diabetes in Spain, representing 6.66% of the population of the above-mentioned age assigned to primary care in the Spanish National Health System (44,721,909 people; 96.25% of the Spanish population of 46,450,975 in that year according to the National Institute of Statistics).5 The prevalence adjusted to the European population was 6.77%.

As shown in Table 1 and graphically displayed by the map in Fig. 1, there were substantial differences in the crude and the adjusted prevalences of the Spanish population between some ACs and others in the country. The adjusted prevalence rates ranged from 4.51% in Castilla y León to 9.72% in the Canary Islands.

Table 1.

Prevalence (crude and adjusted to the Spanish population [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016.

Population  Crude rate  Adjusted rate  [0,4–5]95%CI
Andalucía  7.13  7.92  7.90  7.94 
Aragón  6.81  6.26  6.22  6.28 
Asturias  7.12  5.75  5.71  5.80 
Balearic Islands  6.19  7.10  7.05  7.11 
Canary Islands  8.63  9.72  9.68  9.77 
Cantabria  6.26  5.68  5.62  5.74 
Castile and León  5.52  4.51  4.49  4.54 
Castile La Mancha  5.74  5.78  5.74  5.81 
Catalonia  6.07  6.03  6.01  6.04 
Valencian Community  7.73  7.72  7.70  7.75 
Extremadura  5.85  5.56  5.51  5.60 
Galicia  7.85  6.52  6.50  6.55 
Madrid  5.73  6.26  6.24  6.28 
Murcia  7.89  9.29  9.23  9.34 
Navarra  5.86  5.74  5.68  5.74 
Basque Country  5.88  5.25  5.22  5.28 
La Rioja  5.82  5.49  5.41  5.57 
Spain  6.66  6.66  6.65  6.66 
Figure 1.

Adjusted prevalence of diabetes mellitus according to total assigned population.

(0.08MB).

A total of 53.49% of the people with diabetes (1,592,095) were males and 46.51% were females (1,384,185). The crude prevalence in males was 7.27%, which was significantly higher (P < .001) than in females (6.06%).

The prevalence was higher from 30 years of age onwards, and increased as age progressed to 80 years, followed by a decrease (Fig. 2). In all age groups the prevalence was higher in males than in females up until 80 years of age (Table 2), and then proved similar in both genders beyond that age.

Figure 2.

Prevalence of diabetes mellitus according to age and gender groups.

(0.18MB).
Table 2.

Prevalence (crude and adjusted [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016, in individuals aged 30 years or older (adjusted to the Spanish population).

  [0,2–5]Total[0,6–9]Males[0,10–13]Females
  Crude prevalence  Adjusted prevalence  [0,4–5]95%CICrude prevalence  Adjusted prevalence  [0,8–9]95%CICrude prevalence  Adjusted prevalence  [0,12–13]95%CI
Andalucía  10.39  11.12  11.09  11.15  11.25  12.05  12.01  12.10  9.59  10.48  10.44  10.51 
Aragón  9.40  8.82  8.76  8.88  10.64  10.14  10.05  10.24  8.20  7.66  7.59  7.74 
Asturias  9.13  8.10  8.04  8.13  10.10  9.08  8.99  9.17  8.25  7.34  7.26  7.39 
Balearic Islands  8.96  10.02  9.94  10.10  10.34  11.55  11.43  11.67  7.60  8.72  8.62  8.82 
Canary Islands  12.22  13.66  13.66  13.68  12.92  14.28  14.18  14.37  11.56  13.32  13.23  13.34 
Cantabria  8.46  8.03  7.95  8.12  9.64  9.23  9.10  9.36  7.37  7.08  6.97  7.19 
Castile and León  7.32  6.33  6.29  6.36  7.99  7.01  6.96  7.07  6.70  5.74  5.69  5.78 
Castile La Mancha  8.24  8.11  8.06  8.16  9.22  9.21  9.13  9.28  7.26  7.16  7.10  7.22 
Catalonia  8.54  8.49  8.46  8.51  9.56  9.66  9.62  9.70  7.60  7.61  7.58  7.64 
Valencian Community  10.85  10.82  10.79  10.86  12.17  12.21  12.15  12.26  9.63  9.72  9.68  9.73 
Extremadura  8.18  7.75  7.69  7.75  8.40  8.08  7.99  8.17  7.99  7.58  7.49  7.66 
Galicia  10.31  9.17  9.13  9.21  11.60  10.50  10.44  10.56  9.14  8.10  8.05  8.15 
Madrid  8.18  8.80  8.77  8.83  9.44  10.26  10.22  10.29  7.06  7.71  7.67  7.75 
Murcia  11.83  13.10  13.10  13.17  12.98  14.57  14.45  14.69  10.69  11.88  11.77  11.98 
Navarra  8.31  8.06  7.98  8.15  9.45  9.19  9.06  9.32  7.20  7.04  6.93  7.15 
Basque Country  7.97  7.41  7.37  7.45  9.06  8.56  8.50  8.63  6.99  6.52  6.47  6.58 
La Rioja  8.06  7.70  7.58  7.81  9.29  8.92  8.75  9.10  6.81  6.51  6.36  6.66 
Spain  9.34  9.34  9.33  9.35  10.40  10.50  10.48  10.50  8.37  8.45  8.44  8.46 

The crude prevalence of diabetes in the population between 20–79 years of age was 6.95%, versus 7.56% adjusted to the European population of the same age (Table 3).

Table 3.

Prevalence (crude and adjusted [%]) of diagnosed diabetes mellitus in Spain and its Autonomous Communities in 2016, in individuals aged 20–79 years or older (adjusted to the European population).

  Crude prevalence  Adjusted prevalence  [0,4–5]95%CI
Andalucía  7.56  8.80  8.77  8.83 
Aragón  6.72  7.00  6.95  7.02 
Asturias  6.94  6.48  6.48  6.49 
Balearic Islands  6.71  8.09  8.02  8.16 
Canary Islands  9.24  10.98  10.92  10.99 
Cantabria  6.37  6.45  6.37  6.48 
Castile and León  5.17  5.03  5.00  5.06 
Castile La Mancha  6.08  6.73  6.69  6.75 
Catalonia  6.60  7.12  7.09  7.12 
Valencian Community  8.14  8.62  8.58  8.62 
Extremadura  5.89  6.32  6.26  6.38 
Galicia  7.76  7.47  7.43  7.51 
Madrid  5.93  6.87  6.84  6.87 
Murcia  8.67  10.45  10.38  10.52 
Navarra  5.93  6.26  6.18  6.33 
Basque Country  5.92  5.87  5.83  5.91 
La Rioja  5.72  6.02  5.91  6.12 
Spain  6.95  7.56  7.55  7.56 
Discussion

The prevalence of diabetes in Spain has been estimated from either national epidemiological studies such as the di@bet.es study6 conducted in 2010, or data from the national health survey.7

The present study with data from 2016 reports the prevalence of diagnosed diabetes in the population assigned to the public health services throughout Spain, representing practically the entire population of the country (96.25%). The crude prevalence of diabetes is 6.66% of the total Spanish population, which in the population aged 20–79 years is 7.56% when adjusted to the European population. This prevalence is similar to that recently documented in Portugal8 and is considerably higher than the diagnosed diabetes rates in other countries such as France,9 Ireland,10 Italy11 and Norway.12

The data from the national health survey with information reported by the participants shows a gradual increase in the prevalence of diabetes in recent years. In 2012, the prevalence among individuals over 15 years of age was 7.4% (adjusted to 7.1%),7 which is similar to that found in our study.

In the di@bet.es study, the prevalence of diabetes was 13.8% among individuals 18–89 years of age, and diabetes was diagnosed in 7.8% of that population.6 This prevalence was similar to that seen in other southern European countries such as Portugal,13 but notably higher than that recorded in northern European countries.14 It was also very similar to that reported in our study, perhaps indicating a stabilization of the prevalence in recent years.

The di@bet.es study lacked the statistical power to differentiate prevalence among the different zones of Spain, though the prevalence of diabetes in Andalusia was seen to be much higher than in the rest of the country, as was the prevalence of obesity and a sedentary lifestyle.15 Other regional studies have reported a prevalence of diagnosed diabetes lower than that observed in our study, though the data were from earlier years.16,17 In the Canary Islands, the prevalence of confirmed diabetes was already as high as 9% in 2005,18 and this prevalence has recently been found still to be higher than that of the rest of Spain.19

For the first time we can compare the regional differences in the crude and adjusted prevalence of diagnosed diabetes. These differences are very substantial between some parts of Spain and others. The crude prevalence ranges from 5.52% in Castilla y León to 8.63% in the Canary Islands. However, on comparing the adjusted rates, these figures undergo significant changes due to the different degrees of population aging in the various ACs. In this regard, the map shows that in northern and central Spain the adjusted prevalence is under 6%, with the exception of Madrid. In the south of the country this prevalence ranges from 6% to 8%. However, there are two regions with a prevalence above 9%: Murcia (9.29%) and the Canary Islands (9.72%).

The explanation for these differences may be found in the differences in the obesity rates, since different studies have shown the frequency of obesity and abdominal obesity in Spain to be higher in the Canary Islands and in the southern and eastern regions of the country,20,21 such as Andalusia,15 in concordance with the prevalence of diabetes found in our study.

As in all developed countries, most people diagnosed with diabetes are over 50 years of age,14 and in the concrete case of Spain this age group accounts for over 90% of all people with diabetes.

The prevalence of diabetes was higher in men than in women. This finding is consistent with the results of the European Health Examination Pilot Project.22 The gender difference may be due to the fact that men develop diabetes at lower levels of abdominal obesity than women. Previous studies on adipose tissue distribution, insulin resistance, sex hormones and blood glucose levels between males and females have corroborated this hypothesis.23

As in many other publications, a limitation of our study is the fact that no differentiation could be made between type 1 and type 2 diabetes mellitus; however, type 2 diabetes accounts for over 90% of all cases of diabetes, and our results therefore mainly reflect type 2 diabetes.

In conclusion, the present study estimates the prevalence of diagnosed diabetes in the National Health System to be 6.66% of the total population. The disease is more common in men, and increases in frequency up to 80 years of age. The differences between ACs are very important, with generally a lower prevalence in the north and central parts of the country and a higher prevalence in the east and south, with the highest levels being recorded in the Canary Islands.

Financial support

The present study has received no funding.

Conflicts of interest

There are no conflicts of interest in relation to the present study.

References
[1]
International Diabetes Federation.
IDF diabetes atlas.
Eighth edition 2017edn 8th ed, International Diabetes Federation, (2017), pp. 1-150
[2]
J. Ares, S. Valdés, P. Botas, C. Sánchez-Ragnarsson, S. Rodríguez-Rodero, P. Morales-Sánchez, et al.
Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: the Asturias study.
PLoS One., 79 (2019), pp. 1-13
[3]
Diseño y metodología de la BDCAP, Madrid 2014 [Accessed13 Dec 2019]. Available from: https://www.mscbs.gob.es/estadEstudios/estadisticas/estadisticas/estMinisterio/SIAP/DisenoBDCAP.pdf.
[4]
Eurostat.
Revision of the European Standard Population: report of Eurostat’s tak force [Internet].
[5]
Instituto Nacional de Estadística. (National Statistics Institute) [Internet]. Available from: http://www.ine.es/.
[6]
F. Soriguer, A. Goday, A. Bosch-Comas, E. Bordiú, A. Calle-Pascual, R. Carmena, et al.
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study.
[7]
F.J. Basterra-Gortari, M. Bes-Rastrollo, M. Ruiz-Canela, A. Gea, M.Á. Martinez-Gonzalez.
Prevalencia de obesidad y diabetes en adultos españoles, 1987-2012.
[8]
M. Barreto, I. Kislaya, V. Gaio, A.P. Rodrigues, A.J. Santos, S. Namorado, et al.
Prevalence, awareness, treatment and control of diabetes in Portugal: results from the first National Health examination Survey (INSEF 2015).
[9]
C. Bonaldi, M. Vernay, C. Roudier, B. Salanave, A. Oleko, A. Malon, et al.
Epidemiology a first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals : the French Nutrition and Health Survey 2006 / 2007.
Diabet Med., 28 (2011), pp. 583-589
[10]
M.L. Tracey, S.M. Mchugh, C.M. Buckley, R.J. Canavan, A.P. Fitzgerald, P.M. Kearney.
The prevalence of Type 2 diabetes and related complications in a nationally representative sample of adults aged 50 and over in the Republic of Ireland.
Diabet Med., 33 (2016), pp. 441-445
[11]
R. Gnavi, A. Migliardi, M. Maggini, G. Costa.
Prevalence of and secular trends in diagnosed diabetes in Italy: 1980–2013.
[12]
P.L.D. Ruiz, L.C. Stene, I.J. Bakken, S.E. Håberg, K.I. Birkeland, H.L. Gulseth.
Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study.
Diabetologia., 61 (2018), pp. 2310-2318
[13]
L. Gardete-Correia, J.M. Boavida, J.F. Raposo, A.C. Mesquita, C. Fona, R. Carvalho, et al.
First diabetes prevalence study in Portugal: PREVADIAB study.
Diabet Med., 27 (2010), pp. 879-881
[14]
L. Guariguata, D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, J.E. Shaw.
Global estimates of diabetes prevalence for 2013 and projections for 2035.
[15]
S. Valdés, F. García-Torres, C. Maldonado-Araque, A. Goday, A. Calle-Pascual, F. Soriguer, et al.
Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (Southern Spain). Comparison with National Prevalence Data. The Di@bet.es study.
[16]
I. Vinagre, M. Mata-Cases, E. Hermosilla, R. Morros, F. Fina, M. Rosell, et al.
Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).
Diabetes Care., 35 (2012), pp. 774-779
[17]
P. Botas Cervero, E. Delgado Alvarez, G. Castaño Fernández, C. Díaz De Greñu, J. Prieto Santiago, F.J. Díaz Cadórniga.
Prevalence of diabetes mellitus and glucose intolerance in the population aged 30 to 75 years in Asturias, Spain.
[18]
A. Cabrera de León, J.C. del Castillo Rodríguez, S. Domínguez Coello, M.C. Rodríguez Pérez, B. Brito Díaz, C. Borges Álamo, et al.
Estilo de vida y adherencia al tratamiento de la población Canaria con diabetes mellitus tipo 2.
Rev Esp Salud Publica., 83 (2009), pp. 567-575
[19]
I. Marcelino-Rodríguez, R. Elosua, M.C. Pérez, D. Fernández-Bergés, M.J. Guembe, T.V. Alonso, et al.
On the problem of type 2 diabetes-related mortality in the Canary Islands, Spain. The DARIOS Study.
Diabetes Res Clin Pract., 111 (2016), pp. 74-82
[20]
J.L. Gutiérrez-Fisac, P. Guallar-Castillón, L.M. León-Muñoz, A. Graciani, J.R. Banegas, F. Rodríguez-Artalejo.
Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study.
[21]
M. Grau, R. Elosua, A. Cabrera De León, M.J. Guembe, J.M. Baena-Díez, T. Vega Alonso, et al.
Factores de riesgo cardiovascular en España en la primera década del siglo XXI: Análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS.
Rev Esp Cardiol., 64 (2011), pp. 295-304
[22]
H. Tolonen, P. Koponen, J.S. Mindell, S. Männistö, S. Giampaoli, C.M. Dias, et al.
Under-estimation of obesity, hypertension and high cholesterol by self-reported data: comparison of self-reported information and objective measures from health examination surveys.
Eur J Public Health., 24 (2014), pp. 941-948
[23]
A. Kautzky-Willer, J. Harreiter, G. Pacini.
Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus.
Endocr Rev., 37 (2016), pp. 278-316

Please cite this article as: Menéndez Torre EL, Blanco JA, Barreiro SC, Martínez GR, Alvarez ED. Prevalencia de diabetes mellitus en 2016 en España según la Base de Datos Clínicos de Atención Primaria (BDCAP). Endocrinol Diabetes Nutr. 2021;68:109–115.

Copyright © 2020. SEEN and SED
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos